Please login to the form below

Not currently logged in
Email:
Password:

Sanofi Genzyme

This page shows the latest Sanofi Genzyme news and features for those working in and with pharma, biotech and healthcare.

Sanofi’s rare blood disorder drug Cablivi set for European approval

Sanofi’s rare blood disorder drug Cablivi set for European approval

Rare disease drug among notable CHMP recommendations. Sanofi is closing in on EU approval of Cablivi for acquired thrombotic thrombocytopenic purpura (aTTP) – the lead asset behind its 9.3bn acquisition of ... Europe looks set to be the first market

Latest news

More from news
Approximately 15 fully matching, plus 79 partially matching documents found.

Latest Intelligence

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Voyager Therapeutics/ Sanofi (Genzyme). Gene therapy - Parkinson's disease, Friedreich's ataxia and Huntington's disease.

  • Pharma deals during January 2014 Pharma deals during January 2014

    The other deal announced by Alnylam was the expansion of its deal with Sanofi (Genzyme unit_ to develop RNAi therapeutics in rare diseases. ... In 2008 Genzyme gained rights to ataluren from PTC Therapeutics at a cost of $100m.

  • Interview: Laure Thibaud, Sanofi Interview: Laure Thibaud, Sanofi

    overnight.”. The Genzyme deal, for which Thibaud was involved in the pre-acquisition stage of the agreement, as well as the company's subsequent integration into Sanofi, was particularly exciting, she ... Chris Viehbacher has said too that he was very

  • Who tops the pharma list? Who tops the pharma list?

    The latter, an antiplatelet agent it co-marketed with Sanofi, enjoyed 2011 sales of $9.4bn - but, with Plavix accounting for more than a third of BMS revenues in 2010, the ... For example, Sanofi's 2011 acquisition of Genzyme gave it access to an

  • Personalised medicine is driving new techniques in market research Personalised medicine is driving new techniques in market research

    Parallels in orphan diseases &oncology. Orphan diseases have become an important part of pharma strategy, with significant acquisitions including the deal between Sanofi and Genzyme and key collaborations such as

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Sobi names Holly May VP of sales and marketing, US Sobi names Holly May VP of sales and marketing, US

    at Sanofi Genzyme. ... Prior to her 17-year career at Sanofi, May held various sales positions at DuPont Pharmaceuticals and Endo.

  • Sanofi appoints Bill Sibold to lead its Genzyme business Sanofi appoints Bill Sibold to lead its Genzyme business

    Sanofi has appointed Bill Sibold as executive vice president for Sanofi Genzyme in a move that will also see he join the company's executive committee. ... Previously head of Sanofi Genzyme’s multiple sclerosis, oncology and immunology organisation,

  • Dr Irina Antonijevic joins vasopharm Dr Irina Antonijevic joins vasopharm

    Most recently, Dr Antonijevic served as global head of early development in neurology, multiple sclerosis and ophthalmology at Sanofi Genzyme in the US.

  • ImmuneXcite boosts senior leadership ImmuneXcite boosts senior leadership

    Genzyme. DeWitt is senior director of investments at Sanofi-Genzyme BioVentures and brings business leadership experience from Springboard Enterprises, Permeon Biologics and Flagship Ventures. ... He is chairman of the board of Idera Pharmaceuticals and

  • Former Genzyme group vice president joins Vedanta Biosciences Former Genzyme group vice president joins Vedanta Biosciences

    Former Genzyme group vice president joins Vedanta Biosciences. Dr Bruce Roberts takes up the role of chief scientific officer. ... He first joined Sanofi Genzyme as general manager of its Cambridge, UK-based therapeutic antibody centre in 2004 before

More from appointments
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics